# Advisor Review - Gemini-3-Flash

**Role:** Academic advisor checking for fatal errors
**Model:** gemini-3-flash-preview (ai_studio)
**Paper:** paper.pdf
**Timestamp:** 2026-03-10T09:32:44.863387
**Route:** Direct Google API + PDF
**Paper Hash:** 84dfeac49160074b
**Tokens:** 18838 in / 710 out
**Response SHA256:** 0d484363be545aca

---

I have reviewed the draft paper for fatal errors that would preclude submission to a journal.

### FATAL ERROR 1: Internal Consistency (Data vs. Analysis)
**Location:** Abstract (Page 1), Section 3.1 (Page 6), and Section 3.4 (Page 8).
**Error:** The Abstract claims to find "near-complete pass-through... persistent for 24 months." However, the data period is stated as "January 2015 to December 2024" (Page 6). If the treatment occurred in October 2019, the data actually covers **63 months** post-treatment (as correctly noted in the Table 1 notes).
**Fix:** Align the claims in the Abstract and throughout the text with the actual data coverage. Specifically, change the "24 months" claim to reflect the full 63-month post-treatment window available in the dataset.

### FATAL ERROR 2: Internal Consistency (Table 2 vs. Table 8)
**Location:** Table 8, Row 1 (Page 34) and Table 2 (Page 14).
**Error:** Table 8 reports the result for "Log relative price (eat-in/takeout) DD, Table 2 Col. 2" as **0.0204**. However, Table 2, Column 2 explicitly reports the coefficient for "Post × Differential" as **0.0204***. While the numbers match, Table 8 characterizes the effect as "Large positive" based on an SDE of 6.38, while the main text (Page 13) notes this specific estimate "exceeds the predicted full-pass-through value of 0.0183." 
**Fix:** This is a minor consistency check, but ensure the interpretation of the magnitude (0.0204 vs 0.0183) is consistent between the results section and the standardized effect size appendix.

### FATAL ERROR 3: Regression Sanity (Table 2, Column 1)
**Location:** Table 2, Column 1 (Page 14).
**Error:** The coefficient for the "Full Sample" (0.0078) is significantly smaller than the predicted tax wedge (0.0183). The text on Page 13 explains this is due to "post-COVID reversion." However, the COVID indicator in Column 4 yields a coefficient of 0.0216, which is more than double the full-sample estimate. If the COVID indicator is a simple level shift (as implies by Eq 5), it should not cause such a massive swing in the treatment coefficient unless there is an unaddressed trend or the "Full Sample" estimate in Column 1 is being heavily biased by the inclusion of the 2022-2024 period.
**Fix:** The paper should reconcile why the "Full Sample" estimate (0.0078) is reported as the primary result in Table 2, Col 1 when it is clearly biased by the post-2021 reversal shown in Figure 1. Either lead with the Pre-COVID estimate or use a specification that accounts for the reversal in the main column.

---

**ADVISOR VERDICT: FAIL**